PREVALENCE OF CARDIORENAL SYNDROME IN PATIENTS ADMITTED FOR ACUTE DECOMPENSATED HEART FAILURE AND ITS CORRELATION WITH IN-HOSPITAL OUTCOMES
DOI:
https://doi.org/10.55519/JAMC-04-13921Keywords:
Prevalence, Cardiorenal syndrome, In-hospital, tertiary careAbstract
Background: Cardiorenal syndrome is the prevalent form of the syndrome in Pakistan. Despite the rising importance of CRS, more information is needed to understand comorbidities and hospital outcomes. This research study explores the prevalence, and In-hospital outcomes of patients admitted for Acute Decompensated Heart Failure at the tertiary care hospital of Islamabad at the age of above 18. Methods: This cohort study was conducted at the tertiary care hospital in Islamabad from January 2024 to June 2024. Data were collected from 200 known ADHF patients who visited the CCU (OPD) and ward through a structured questionnaire. The data were analyzed using SPSS version 25. Result: The majority of the sample was diagnosed with Type 1 Cardiorenal Syndrome, which accounted for 30% of the total. Cardiorenal Syndrome Types 3 and 5 had a prevalence of 20% each among the patients, while Types 2 and 4 had a prevalence of 15% each. This suggests that Type 1 was more prevalent, but the other types were equally distributed. The mortality rate in the Hospital was highest for Type 5 CRS at 15% and Type 3 CRS at 13%. During this period, Type 2 CRS exhibited the lowest mortality rate. Type 3 CRS had the most extended average hospitalization duration. Conclusion: It was concluded in our study that cardiorenal syndrome is the prevalent form among admitted patients with ADHF, and the government needs to increase awareness about health and health-related risk factors related to the communities.
References
1. House AA, Anand I, Bellomo R, Cruz D, Bobek I, Anker SD, et al. Definition and classification of Cardio-Renal Syn-dromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010;25(5):1416–20.
2. Bargshaw SM, Cruz DM, Aspromonte N, Daliento L, Ronco F, Sheinfeld G, et al. Epidemiology of cardio–renal syn-dromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010;25(5):1406–16.
3. Dar O, Cowie MR. Acute heart failure in the intensive care unit: epidemiology. Crit Care Med 2008;36(1):S3–8.
4. Aronson D. Cardiorenal syndrome in acute decompensated heart failure. Expert Rev Cardiovasc Ther 2012;10(2):177–89.
5. Blair JE, Pang PS, Schrier RW, Metra M, Traver B, Cook T, et al. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J 2011;32(20):2563–72.
6. Zahoor S, Arshad MS, Riaz A, Farhan M. Precipitants of acute decompensated heart failure and their correlation with the severity of decompensation in a resource poor country. J Islamabad Med Dent Coll 2017;6(4):219–23.
7. DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 national hospital discharge survey. Natl Health Stat Report 2008;5:1–20.
8. Zaidi M, Rehman AJ, Haque A, Akhtar S, Maheshwar PK. Frequency of cardiorenal syndrome type-I in hospitalized children with acute heart failure in a tertiary-care hospital. J Coll Physicians Surg Pak 2014;24(8):577–80.
9. Naqvi R. Thrombotic Microangiopathy and acute kidney injury with malaria: One-year experience at SIUT. Pak J Kid-ney Dis 2024;8(2):23–6.
10. Usman MS, Khan MS, Butler J. The interplay between diabe-tes, cardiovascular disease, and kidney disease. In: Chronic Kidney Disease and Type 2 Diabetes. Arlington (VA): Ameri-can Diabetes Association; 2021.
11. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31(6):703–11.
12. Ronco C, Di Lullo L. Cardiorenal syndrome in western coun-tries: epidemiology, diagnosis and management approaches. Kidney Dis (Basel) 2017;2(4):151–63.
13. Zarbock A, Küllmar M, Ostermann M, Lucchese G, Baig K, Cennamo A, et al. Prevention of cardiac surgery–associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: The PrevAKI-multicenter randomized controlled trial. Anesth Analg 2021;133(2):292–302.
14. Syed M. Hyponatremia in acute decompensated heart failure as a predictor of acute cardiorenal syndrome Type-1. Indian J Cardiovasc Dis Women 2023;8(2):121–5.
15. Maisons V, Halimi JM, Fauchier G, de Fréminville JB, Goin N, Gueguen J, et al. Type 2 diabetes and cardiorenal syn-dromes. A nationwide French hospital cohort study. Diabetes Metab 2023;49(3):101441.
16. Prothasis M, Varma A, Gaidhane S, Kumar S, Khatib N, Za-hiruddin QS, et al. Prevalence, types, risk factors, and out-comes of cardiorenal syndrome in a rural population of cen-tral India: A cross-sectional study. J Family Med Prim Care 2020;9(8):4127–33.
17. Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, et al. Cardio-vascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci 2014;18(19):2918–26.
18. Kumar A, Shandil R, Gupta D, Ganju N, Shandil A, Shandil A. Clinical profile and outcome of patients with cardiorenal syndrome type 1: a cross sectional observational study. Eur J Cardiovasc Med 2023;13(4):258.
19. Nakayama M. Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective. Perit Dial Int 2013;33(1):8–14.
20. Gigante A, Liberatori M, Gasperini ML, Sardo L, Di Mario F, Dorelli B, et al. Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medi-cine ward. Cardiorenal Med 2014;4(2):88–94.
21. Pimienta González R, Couto Comba P, Rodríguez Esteban M, Alemán Sánchez JJ, Hernández Afonso J, Rodríguez Pérez MD, et al. Incidence, mortality and positive predictive value of type 1 cardiorenal syndrome in acute coronary syndrome. PLoS One 2016;11(12):e0167166.
22. Dreznik Y, Hoffman A, Hamburger T, Ben-Yaacov A, Dux Y, Jacoby H, et al. Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peri-toneal surface malignancies. Surgeon 2018;16(5):278–82.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Naveed Yaqoob, Fahad Khalid, Muhammad Fareed Khan, Wahab Anwar, Muhammad fasihullah Khan, Muhammad hasnain iqbal
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
